Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease

Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease

Metformin and liraglutide are used in the treatment of type 2 diabetes mellitus (T2DM) complicated with nonalcoholic fatty liver disease (NAFLD). Although these drugs can alter the intestinal microbiome, clinical data are required to explore their mechanisms of action. Using 16S sequencing technolog...

Full description

Bibliographic Details
Main Authors: Xing Ying, Zheng Rongjiong, Mayila Kahaer, Jiang Chunhui, Muhuyati Wulasihan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Microbiology
Subjects:
intestinal microorganism
NAFLD
T2DM
liraglutide
metformin
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1088187/full

Similar Items

Similar Items